These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2815872)

  • 1. [Risk assessment of the industrial application of genetically engineered microorganisms].
    Smalla K; Isemann M; Levy R; Thriene B
    Z Gesamte Hyg; 1989; 35(8):475-7. PubMed ID: 2815872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conceptualizing "suicidal genetically engineered microorganisms" for bioremediation applications.
    Pandey G; Paul D; Jain RK
    Biochem Biophys Res Commun; 2005 Feb; 327(3):637-9. PubMed ID: 15649393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suicidal genetically engineered microorganisms for bioremediation: need and perspectives.
    Paul D; Pandey G; Jain RK
    Bioessays; 2005 May; 27(5):563-73. PubMed ID: 15832375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Problems in the introduction of genetically engineered microorganisms into the environment.
    Gorlach K
    Acta Microbiol Pol; 1994; 43(2):121-31. PubMed ID: 7530892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fate of genetically-engineered bacteria in activated sludge microcosms.
    Dwyer DF; Hooper SW; Rojo F; Timmis KN
    Schriftenr Ver Wasser Boden Lufthyg; 1988; 78():267-76. PubMed ID: 3074483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetically engineered bacteria: an emerging tool for environmental remediation and future research perspectives.
    Singh JS; Abhilash PC; Singh HB; Singh RP; Singh DP
    Gene; 2011 Jul; 480(1-2):1-9. PubMed ID: 21402131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applicability of chemical risk assessment methodologies to risk assessment for genetically engineered microorganisms.
    Dean-Ross D
    Recomb DNA Tech Bull; 1986 Mar; 9(1):16-28. PubMed ID: 3458267
    [No Abstract]   [Full Text] [Related]  

  • 8. Problems and potential for in situ treatment of environmental pollutants by engineered microorganisms.
    Jain RK; Sayler GS
    Microbiol Sci; 1987 Feb; 4(2):59-63. PubMed ID: 3153173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of synthetic proteinase inhibitors of the level of human recombinant proinsulin production, secreted by a genetically engineered strain of Bacillus subtilis].
    Parfenova EV; Popov DG; Novikov AA; Sterkin VE; Strongin AIa; Aksinenko AIu; Korenchenko OV; Fetisov VI; Martynov IV; Sokolov VB
    Bioorg Khim; 1989 Jul; 15(7):987-9. PubMed ID: 2510738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Setting free genetically-engineered microorganisms from the environmental hygiene point of view].
    Seeber E
    Schriftenr Ver Wasser Boden Lufthyg; 1988; 78():305-6. PubMed ID: 3249945
    [No Abstract]   [Full Text] [Related]  

  • 11. Environmental issues in the planned release of genetically-engineered organisms.
    Sarma V
    Aust J Biotechnol; 1989 Jan; 3(1):13-6. PubMed ID: 2485312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant bacteria for environmental release: what went wrong and what we have learnt from it.
    de Lorenzo V
    Clin Microbiol Infect; 2009 Jan; 15 Suppl 1():63-5. PubMed ID: 19220359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Special conditions for the cultivation of genetically engineered microorganisms].
    Krug M; Weide H
    Zentralbl Mikrobiol; 1987; 142(8):595-604. PubMed ID: 3328447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative approaches for assessing the ecological sustainability of in situ bioremediation.
    Pandey J; Chauhan A; Jain RK
    FEMS Microbiol Rev; 2009 Mar; 33(2):324-75. PubMed ID: 19178567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmids in the environment.
    Linton AH
    Schriftenr Ver Wasser Boden Lufthyg; 1988; 78():197-224. PubMed ID: 3074480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Horizontal gene transfer between bacteria.
    Heuer H; Smalla K
    Environ Biosafety Res; 2007; 6(1-2):3-13. PubMed ID: 17961477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications for the release of genetically engineered organisms.
    Pickup RW; Morgan JA; Winstanley C; Saunders JR
    Soc Appl Bacteriol Symp Ser; 1991; 20():19S-30S. PubMed ID: 1887268
    [No Abstract]   [Full Text] [Related]  

  • 18. Biological and biomedical aspects of genetically modified food.
    Celec P; Kukucková M; Renczésová V; Natarajan S; Pálffy R; Gardlík R; Hodosy J; Behuliak M; Vlková B; Minárik G; Szemes T; Stuchlík S; Turna J
    Biomed Pharmacother; 2005 Dec; 59(10):531-40. PubMed ID: 16298508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developments in the use of Bacillus species for industrial production.
    Schallmey M; Singh A; Ward OP
    Can J Microbiol; 2004 Jan; 50(1):1-17. PubMed ID: 15052317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.